Skip to main content
. 2012 Oct 30;15(2):158–165. doi: 10.1093/eurjhf/hfs165

Table 3.

Heart failure-related characteristics of participants by (study-determined) heart failure status

No HF (A), n = 308 LVSD (B), n = 34 HFpEF (C), n = 57 P-value (A vs. B) P-value (A vs. C)
Symptoms
 Orthopnea 36 (11.7%) 10 (29.4%) 17 (29.8%) 0.027a 0.003
Signs and echo findings
 Raised JVPb 25 (8.1%) 7 (20.6%) 10 (17.5%) 0.054a 0.058
 Lung cracklesc 52 (16.9%) 12 (35.3%) 19 (33.3%) 0.031a 0.012
 Oedemad 125 (40.6%) 19 (55.9%) 39 (68.4%) 0.487 0.001
 Systolic BPe 131 (±22) 131 (±26) 135 (±25) 0.896 0.141
 Diastolic BPf 72 (±10) 71 (±13) 68 (±10) 0.213 0.643
 Heart rate 72 (±12) 75 (±13) 74 (±13) 0.630 0.541
 Respiratory rateg 18 (±4) 19 (±4) 18 (±4) 0.293 0.374
 Abnormal ECG 153 (49.7%) 29 (85.3%) 35 (61.4%) <0.001 0.157
 Abnormal diastolic function 85 (27.6%) 14 (41.2%) 56 (98.2%) 0.334 <0.001
 Ejection fraction %h 63.9 (±8.0) 39.0 (±7.1) 56.0 (±2.2) 0.191 0.825
 Severe aortic regurgitationi 0 (0%) 0 (0%) 0 (0%)
 Severe aortic stenosis 3 (1.0%) 2 (5.9%) 2 (3.5%) 0.113a 0.263a
 Severe mitral regurgitationj 2 (0.6%) 1 (2.9%) 1 (1.8%) <0.001 0.004
 Severe mitral stenosisk 0 (0%) 0 (0%) 1 (1.8%) 0.001

BP, blood pressure; ECG, electorcardiogram; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; JVP, jugular venous presure; LVSD, left ventricular systolic dysfunction.

aFisher's exact test (all other P-values show Pearson χ2).

bJVP measurement was available for 384 (96.2%) residents.

cLung assessment was available for 398 (99.7%) residents.

dOedema assessment was available for 397 (99.4%) residents.

eSystolic BP measurement was available for 398 (99.7%) residents.

fDiastolic BP measurement was available for 395 (98.9%) residents.

gRespiratory rate was available for 398 (99.7%) residents.

hEjection fraction % was available for 17 (4%) residents.

iAortic regurgitation measurement was available for 366 (91.7%) residents.

jMitral regurgitation measurement was available for 385 (96.5%) residents.

kMitral stenosis measurement was available for 396 (99.2%) residents. All other measurements were available for the full cohort (n = 399).